Research map: HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis

Back to the article

Papers in this map

  1. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria · Chris H. Polman · 2011 · 9915 citations · Cited by this paper
  2. Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal) · 2026 · Related
  3. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” · Chris H. Polman · 2005 · 5018 citations · Cited by this paper
  4. Steroids or immunoglobulin for CIDP first-line treatment: why not both? · 2026 · Related
  5. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis · Kjetil Bjørnevik · 2022 · 2083 citations · Cited by this paper
  6. Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data · 2026 · Related
  7. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis · Tomas P Olsson · 2016 · 1217 citations · Cited by this paper
  8. Diagnostic performance of machine learning models versus established risk stratification for intracranial aneurysm rupture: a systematic review and bivariate meta-analysis · 2026 · Related
  9. Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications · Kjetil Bjørnevik · 2023 · 252 citations · Cited by this paper
  10. Evaluation of metformin for epilepsy prevention or seizure control in people without evidence of diabetes: retrospective cohort study · 2026 · Related
  11. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk · Katarina Tengvall · 2019 · 249 citations · Cited by this paper
  12. Acquired vitamin B6 deficiency in POEMS: a marker of disease activity and cause of neuropathy? · 2026 · Related
  13. Multi-Population Classical HLA Type Imputation · Alexander Dilthey · 2013 · 223 citations · Cited by this paper
  14. DNA methylation profiling in central nervous system tumours · 2026 · Related
  15. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI · Rachel A Farrell · 2009 · 217 citations · Cited by this paper
  16. Migration status, country of origin and long-term outcomes in multiple sclerosis: a Swedish nationwide study · 2026 · Related
  17. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis · Olivia G. Thomas · 2023 · 144 citations · Cited by this paper
  18. Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study · 2026 · Related
  19. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT · Kassandra L. Munger · 2015 · 64 citations · Cited by this paper
  20. Visuospatial working memory in Huntington’s disease: behavioural and structural brain correlates · 2026 · Related
  21. Anti‐EBNA‐1 IgG is not a reliable marker of multiple sclerosis clinical disease activity · Gillian Ingram · 2010 · 59 citations · Cited by this paper
  22. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection · Anna Karin Hedström · 2023 · 58 citations · Cited by this paper
  23. Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls · Neda Sattarnezhad · 2025 · 56 citations · Cited by this paper
  24. The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma · Kimberley Jones · 2015 · 46 citations · Cited by this paper
  25. Function of multiple sclerosis-protective HLA class I alleles revealed by genome-wide protein-quantitative trait loci mapping of interferon signalling · Christian Lundtoft · 2020 · 29 citations · Cited by this paper
  26. DRB1–environment interactions in multiple sclerosis etiology: results from two Swedish case–control studies · Anna Karin Hedström · 2021 · 23 citations · Cited by this paper
  27. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study · María Inmaculada Domínguez‐Mozo · 2022 · 23 citations · Cited by this paper
  28. Immunodominant CD8 T cell response to Epstein-Barr virus · Elisabeth Houssaint · 2001 · 19 citations · Cited by this paper
  29. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy · Brit Ellen Rød · 2023 · 15 citations · Cited by this paper
  30. The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment · Hoai Phuong T. Pham · 2023 · 13 citations · Cited by this paper
  31. Impact of lifestyle factors post-infectious mononucleosis on multiple sclerosis risk · Eva M Johansson · 2025 · 7 citations · Cited by this paper
  32. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression · María Inmaculada Domínguez‐Mozo · 2024 · 6 citations · Cited by this paper
  33. Evaluating the role of anti-EBV antibodies as biomarkers for the evolution of multiple sclerosis: A longitudinal study · Mehak Semy · 2025 · 3 citations · Cited by this paper
  34. Occupational Exposure to Industrial Dust and Rates of Multiple Sclerosis · Lars S. Alfredsson · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)